Masoud Tafavvoghi,
Lars Ailo Aslaksen Bongo,
Nikita Shvetsov,
Lill-Tove Rasmussen Busund,
Kajsa Møllersen
:
Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review
Journal of Pathology Informatics 2024
ARKIV /
DOI
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
André Berli Delgado,
Eline Sol Garthsdatter Tylden,
Marko Lukic,
Line Haugan Moi,
Lill-Tove Rasmussen Busund,
Eiliv Lund
et al.:
Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Eiliv Lund,
Lill-Tove Rasmussen Busund,
Lars Holden
:
The curvilinear relationships between grand parity and incidence of hormone-dependent cancers; follow-up of postmenopausal women in the Norwegian 1960 Census
Nikita Shvetsov,
Morten Grønnesby,
Edvard Pedersen,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund,
Ruth Schwienbacher
et al.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
Marta Tellez Gabriel,
Xavier Tekpli,
Trine M. Reine,
Beate Hegge,
Stephanie Rose Nielsen,
Meng Chen
et al.:
Serglycin is Involved in TGF-β induced epithelial-mesenchymal transition and is highly expressed by immune cells in breast cancer tissue
Frontiers in Oncology 14. April 2022
ARKIV /
DOI
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021
DOI
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Mie Jareid,
Igor Snapkov,
Marit Holden,
Lill-Tove Rasmussen Busund,
Eiliv Lund,
Therese Haugdahl Nøst
:
The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort
Karina Standahl Olsen,
Marit Holden,
Jean-Christophe Thalabard,
Lill-Tove Rasmussen Busund,
Eiliv Lund,
Lars Holden
:
Global blood gene expression profiles following a breast cancer diagnosis—Clinical follow-up in the NOWAC post-genome cohort
Eiliv Lund,
Marit Holden,
Jean-Christophe Thalabard,
Lill-Tove Rasmussen Busund,
Igor Snapkov,
Lars Holden
:
Signals of Death - Post-Diagnostic Single Gene Expression Trajectories in Breast Cancer - A Proof of Concept
Lill-Tove Rasmussen Busund
:
Hypothesis of Carcinogenesis - The Atavistic Theory
Universitetsforlaget 2020
DOI
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Elin Richardsen,
Sigve Andersen,
Christian Melbø-Jørgensen,
Mehrdad Rakaee,
Nora Ness,
Samer Al-Saad
et al.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Line Moi,
Tonje Braaten,
Khalid Al-Shibli,
Eiliv Lund,
Lill-Tove Rasmussen Busund
:
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
Journal of Translational Medicine 2019
ARKIV /
DOI
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
et al.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
et al.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018
DOI
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
et al.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Thea K.W. Grindstad,
Elin Richardsen,
Sigve Andersen,
Kaja Konstanse Skjefstad,
Mehrdad Rakaee,
Tom Dønnem
et al.:
Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
Eiliv Lund,
Lill-Tove Busund,
Jean-Christophe Thalabard
:
Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft
Yury Kiselev,
Sigve Andersen,
Charles Johannessen,
Bjørn Fjukstad,
Karina Standahl Olsen,
Helge Stenvold
et al.:
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
et al.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Yngve Nordby,
Elin Richardsen,
Nora Ness,
Tom Dønnem,
Hitendra R.H. Patel,
Lill-Tove Busund
et al.:
High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
Yngve Nordby,
Elin Richardsen,
Mehrdad Rakaee,
Nora Ness,
Tom Dønnem,
Hitendra R.H. Patel
et al.:
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
et al.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
et al.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Cancer Immunology and Immunotherapy 2017
ARKIV /
DOI
Sigve Andersen,
Elin Richardsen,
Mehrdad Rakaee,
Helena Bertilsson,
Roy M. Bremnes,
Magne Børset
et al.:
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
Eric J. Duell,
Leila Lujan-Barroso,
Núria Sala,
Samantha Deitz McElyea,
Kim Overvad,
Anne Tjønneland
et al.:
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
International Journal of Cancer 2017
ARKIV /
DOI
Åslaug Helland,
Odd Terje Brustugun,
Sigve Nakken,
Ann Rita Halvorsen,
Tom Dønnem,
Roy M. Bremnes
et al.:
High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
International Journal of Cancer 2017
ARKIV /
DOI
Nora Ness,
Sigve Andersen,
Mehrdad Rakaee,
Cecilie Nordbakken,
Andrey Yurjevich Valkov,
Erna-Elise Paulsen
et al.:
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
Charles Johannessen,
Line Moi,
Yury Kiselev,
Mona Irene Pedersen,
Stig Manfred Dalen,
Tonje Braaten
et al.:
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
Sigve Andersen,
Elin Richardsen,
Line Moi,
Tom Dønnem,
Yngve Nordby,
Nora Ness
et al.:
Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a
multicenter (in situ hybridization)study
Thea Grindstad,
Kaja Skjefstad,
Sigve Andersen,
Nora Ness,
Yngve Nordby,
Samer Al-Saad
et al.:
Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome
Mehrdad Rakaee,
Lill-Tove Busund,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Sigve Andersen
et al.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
et al.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach